Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Effect of resveratrol on 17beta-estradiol sulfation by human hepatic and jejunal S9 and recombinant sulfotransferase 1E1.

Furimsky AM, Green CE, Sharp LE, Catz P, Adjei AA, Parman T, Kapetanovic IM, Weinshilboum RM, Iyer LV.

Drug Metab Dispos. 2008 Jan;36(1):129-36. Epub 2007 Oct 22.

3.
4.
5.

Sulfation of resveratrol in human liver: evidence of a major role for the sulfotransferases SULT1A1 and SULT1E1.

Miksits M, Maier-Salamon A, Aust S, Thalhammer T, Reznicek G, Kunert O, Haslinger E, Szekeres T, Jaeger W.

Xenobiotica. 2005 Dec;35(12):1101-19.

PMID:
16418064
6.

Regioselective monosulfation and disulfation of the phytoestrogens daidzein and genistein by human liver sulfotransferases.

Nakano H, Ogura K, Takahashi E, Harada T, Nishiyama T, Muro K, Hiratsuka A, Kadota S, Watabe T.

Drug Metab Pharmacokinet. 2004 Jun;19(3):216-26.

7.

Sulfotransferase 1E1 is a low km isoform mediating the 3-O-sulfation of ethinyl estradiol.

Schrag ML, Cui D, Rushmore TH, Shou M, Ma B, Rodrigues AD.

Drug Metab Dispos. 2004 Nov;32(11):1299-303.

8.
9.

Celecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.

Ambadapadi S, Wang PL, Palii SP, James MO.

J Steroid Biochem Mol Biol. 2017 Sep;172:46-54. doi: 10.1016/j.jsbmb.2017.05.012. Epub 2017 May 25.

PMID:
28552400
10.

Sulfation of environmental estrogens by cytosolic human sulfotransferases.

Nishiyama T, Ogura K, Nakano H, Kaku T, Takahashi E, Ohkubo Y, Sekine K, Hiratsuka A, Kadota S, Watabe T.

Drug Metab Pharmacokinet. 2002;17(3):221-8.

11.

Catecholestrogen sulfation: possible role in carcinogenesis.

Adjei AA, Weinshilboum RM.

Biochem Biophys Res Commun. 2002 Mar 29;292(2):402-8.

PMID:
11906176
12.

Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.

Falany JL, Pilloff DE, Leyh TS, Falany CN.

Drug Metab Dispos. 2006 Mar;34(3):361-8. Epub 2005 Dec 28.

13.

Solvent effect on cDNA-expressed human sulfotransferase (SULT) activities in vitro.

Ma B, Shou M, Schrag ML.

Drug Metab Dispos. 2003 Nov;31(11):1300-5.

14.

Quercetin and resveratrol potently reduce estrogen sulfotransferase activity in normal human mammary epithelial cells.

Otake Y, Nolan AL, Walle UK, Walle T.

J Steroid Biochem Mol Biol. 2000 Jul-Aug;73(5):265-70.

PMID:
11070355
15.

Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases.

Li X, Anderson RJ.

Biochem Biophys Res Commun. 1999 Oct 5;263(3):632-9.

PMID:
10512730
16.

In-vitro sulfation of piceatannol by human liver cytosol and recombinant sulfotransferases.

Miksits M, Sulyok M, Schuhmacher R, Szekeres T, Jäger W.

J Pharm Pharmacol. 2009 Feb;61(2):185-91. doi: 10.1211/jpp/61.02.0007.

PMID:
19178765
17.

Cigarette smoke toxicants as substrates and inhibitors for human cytosolic SULTs.

Yasuda S, Idell S, Fu J, Carter G, Snow R, Liu MC.

Toxicol Appl Pharmacol. 2007 May 15;221(1):13-20. Epub 2007 Feb 28.

PMID:
17433394
18.

Estrogen sulfotransferase (SULT1E1) regulates inflammatory response and lipid metabolism of human endothelial cells via PPARγ.

Xu Y, Yang X, Wang Z, Li M, Ning Y, Chen S, Yin L, Li X.

Mol Cell Endocrinol. 2013 Apr 30;369(1-2):140-9. doi: 10.1016/j.mce.2013.01.020. Epub 2013 Feb 4.

PMID:
23384540
19.

Glucuronidation and sulfation of the tea flavonoid (-)-epicatechin by the human and rat enzymes.

Vaidyanathan JB, Walle T.

Drug Metab Dispos. 2002 Aug;30(8):897-903.

20.

Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters.

Kester MH, Bulduk S, van Toor H, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Schuur AG, Brouwer A, Visser TJ.

J Clin Endocrinol Metab. 2002 Mar;87(3):1142-50.

PMID:
11889178

Supplemental Content

Support Center